Scott and White Cancer Institute
Temple, Texas, United States
Cancer treatment center in Temple, Texas
2401 S 31st St, Temple, TX 76508
About Scott and White Cancer Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Scott and White Cancer Institute
During the past decade, Scott and White Cancer Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on
average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
2005-03-01
2014-01-01
Completed
175
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
2004-12-16
2018-05-06
Completed
102
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Scott and White Cancer Institute" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "University of South Florida" with 2 trials
sponsored, "American College of Radiology Imaging Network" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Egetis Therapeutics"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Scott and White Cancer Institute"
#1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Solasia Pharma K.K." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Scott and White Cancer Institute
According to Clinical.Site data, the most researched conditions in "Scott and White Cancer Institute" are
"Breast Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Colorectal Neoplasms" (2 trials), "B-cell Non-Hodgkin Lymphoma" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Scott and White Cancer Institute" in a lesser frequency.
Clinical Trials Intervention Types at Scott and White Cancer Institute
Most popular intervention types in "Scott and White Cancer Institute" are "Drug" (7 trials), "Procedure" (3 trials), "Biological" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "5-fluorouracil" (1 trials), "Aromatase Inhibitor" (1 trials), "Calmangafodipir (2 µmol/kg)" (1 trials) and "Calmangafodipir (5 µmol/kg)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Scott and White Cancer Institute
The vast majority of trials in "Scott and White Cancer Institute" are
9 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Scott and White Cancer Institute
Currently, there are NaN active trials in "Scott and White Cancer Institute".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Scott and White Cancer Institute,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Scott and White Cancer Institute, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".